CIK 0001833214 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SAB Biotherapeutics, Inc.
Sign in to watch- Ticker
- SABS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853899721
- Phone
- 305-845-2813
- Business address
- 777 W 41ST ST, SUITE 401, MIAMI BEACH, FL, 33140
- Former names
- Big Cypress Acquisition Corp.
- 25-NSE Other Notification of Removal from Listing
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- NT 10-Q Other NT 10-Q
- S-8 Other Securities Offered to Employees in Benefit Plans
- EFFECT Other Notice of Effectiveness
- DEFA14A Proxy Proxy Materials
- D Other Notice of Sales of Unregistered Securities
- EFFECT Other Notice of Effectiveness
- NT 10-Q Other NT 10-Q
- AW Other AW
- POS AM Other Post-effective Amendment for Registration Statement
- RW Other RW
- EFFECT Other Notice of Effectiveness
- EFFECT Other Notice of Effectiveness
Page 1 of 2 · 37 filings